Psychemedics Corporation PMD
2.67
0.00
0.00%
as of 2 Mar
- Market cap
- $15.7M
- P/E
- 0.0×
Follow PMD
| Older periods | Mar '24 | Jun '24 | Sep '24 | Dec '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.76 | 0.66 | 0.67 | 0.67 | |
P/FCF ratio |
0.00 | 0.00 | 32.65 | 16.33 | |
P/Operating CF |
(34.49) | 113.92 | 51.77 | 12.90 | |
P/B ratio |
2.60 | 2.38 | 2.50 | 2.56 | |
Price to Tangible BV |
2.60 | 2.38 | 2.50 | 2.56 | |
EV/Sales |
0.70 | 0.60 | 0.62 | 0.61 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 63.87 | |
EV/Operating CF |
(8.80) | (19.33) | 21.86 | 12.93 | |
EV/FCF |
(7.89) | (14.83) | 29.98 | 14.92 | |
Quick Ratio |
1.27 | 1.20 | 1.25 | 1.45 | |
Current Ratio |
1.48 | 1.60 | 1.59 | 1.82 | |
Net Debt/EBITDA |
74.44 | 6.10 | 9.46 | (2.35) | |
Debt/Assets |
2.06% | 0.00% | 0.62% | 0.64% | |
Debt/Equity |
0.04 | 0.00 | 0.01 | 0.01 | |
Asset Turnover |
1.49 | 1.57 | 1.69 | 1.91 | |
Operating CF/Net income |
0.69 | (0.15) | (0.49) | 5.39 | |
Capex/Depreciation |
(0.01) | (0.06) | (0.03) | (0.14) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.90% | 4.00% | 3.32% | 4.05% | |
Selling, General and Administrative Expense of Revenue |
46.29% | 47.84% | 47.57% | 23.53% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
5.54% | 6.07% | 4.64% | 2.10% | |
Graham Net Nets |
0.08 | 0.12 | 0.12 | 0.13 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(27.40%) | (33.19%) | (22.08%) | (14.29%) | |
Free Cash Flow Yield |
(11.81%) | (6.19%) | 3.06% | 6.13% | |
Revenue per Share |
0.92 | 0.81 | 0.88 | 0.75 | |
Operating CF per Share |
(0.08) | 0.02 | 0.04 | 0.17 | |
Capex per Share |
0.00 | (0.01) | 0.00 | (0.01) | |
Free Cash Flow per Share |
(0.08) | 0.01 | 0.04 | 0.16 | |
Cash per Share |
0.24 | 0.25 | 0.24 | 0.24 | |
Shareholders Equity per Share |
1.08 | 0.99 | 0.92 | 0.87 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.08 | 0.99 | 0.92 | 0.87 | |
Free Cash Flow |
(0.48) | 0.08 | 0.25 | 0.96 | |
Working Capital |
2.00 | 2.26 | 2.25 | 2.23 | |
Capital Expenditures |
(0.01) | (0.04) | (0.01) | (0.06) | |
Net Current Asset Value |
1.32 | 1.64 | 1.66 | 1.75 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.01 | |
Net Profit Margin |
(12.84%) | (17.49%) | (10.34%) | 4.27% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.98 | 3.54 | 4.16 | 3.11 | |
Average Payables |
0.96 | 0.73 | 0.91 | 0.61 | |
Average Assets |
14.53 | 13.25 | 11.97 | 10.32 | |
Average Common Equity |
8.22 | 7.43 | 6.44 | 5.90 |
Columns are period end dates